176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.03%
Positive revenue growth while MU is negative. John Neff might see a notable competitive edge here.
191.95%
Gross profit growth above 1.5x MU's 9.89%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
159.23%
EBIT growth above 1.5x MU's 32.40%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
159.23%
Operating income growth above 1.5x MU's 32.40%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
160.20%
Net income growth above 1.5x MU's 4.17%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
161.29%
EPS growth of 161.29% while MU is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
161.29%
Diluted EPS growth of 161.29% while MU is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
0.80%
Share count expansion well above MU's 1.09%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.73%
Diluted share count expanding well above MU's 0.42%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
517.80%
Positive OCF growth while MU is negative. John Neff would see this as a clear operational advantage vs. the competitor.
5868.30%
FCF growth above 1.5x MU's 12.94%. David Dodd would verify if the firm’s strategic investments yield superior returns.
191.98%
10Y revenue/share CAGR above 1.5x MU's 56.04%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
27.81%
5Y revenue/share CAGR above 1.5x MU's 15.63%. David Dodd would look for consistent product or market expansions fueling outperformance.
-27.28%
Negative 3Y CAGR while MU stands at 10.47%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
722.75%
10Y OCF/share CAGR above 1.5x MU's 76.51%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
122.93%
5Y OCF/share CAGR above 1.5x MU's 8.89%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-46.34%
Negative 3Y OCF/share CAGR while MU stands at 109.99%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
107.29%
Similar net income/share CAGR to MU's 114.29%. Walter Schloss would see parallel tailwinds or expansions for both firms.
14.91%
Positive 5Y CAGR while MU is negative. John Neff might view this as a strong mid-term relative advantage.
-65.38%
Negative 3Y CAGR while MU is 124.59%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
449.65%
Positive growth while MU is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
89.75%
Positive 5Y equity/share CAGR while MU is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
12.42%
3Y equity/share CAGR above 1.5x MU's 2.03%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.90%
AR growth is negative/stable vs. MU's 7.32%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-12.99%
Inventory is declining while MU stands at 5.67%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
4.94%
Asset growth above 1.5x MU's 1.19%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.15%
Positive BV/share change while MU is negative. John Neff sees a clear edge over a competitor losing equity.
-1.58%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-2.90%
Our R&D shrinks while MU invests at 13.44%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-15.29%
We cut SG&A while MU invests at 3.42%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.